UA112990C2 - Композиція, яка містить saccharomyces boulardii і супероксиддисмутазу, для боротьби з ожирінням - Google Patents

Композиція, яка містить saccharomyces boulardii і супероксиддисмутазу, для боротьби з ожирінням

Info

Publication number
UA112990C2
UA112990C2 UAA201400940A UAA201400940A UA112990C2 UA 112990 C2 UA112990 C2 UA 112990C2 UA A201400940 A UAA201400940 A UA A201400940A UA A201400940 A UAA201400940 A UA A201400940A UA 112990 C2 UA112990 C2 UA 112990C2
Authority
UA
Ukraine
Prior art keywords
composition containing
superoxidismutase
saccharomyces boulardii
obesity control
containing saccharomyces
Prior art date
Application number
UAA201400940A
Other languages
English (en)
Inventor
Іньяцио Кастальюоло
Паола БРУН
Іммаколата Бузіелло
Нікколо Міралья
Original Assignee
Ньосіс Спа
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньосіс Спа filed Critical Ньосіс Спа
Publication of UA112990C2 publication Critical patent/UA112990C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Композиція, яка міститьі фермент супероксиддисмутазу. Композиція призначена для зниження ризику розвитку метаболічного синдрому, асоційованого з ожирінням.
UAA201400940A 2011-08-03 2012-02-08 Композиція, яка містить saccharomyces boulardii і супероксиддисмутазу, для боротьби з ожирінням UA112990C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001488A ITMI20111488A1 (it) 2011-08-03 2011-08-03 Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
PCT/EP2012/065119 WO2013017650A2 (en) 2011-08-03 2012-08-02 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity

Publications (1)

Publication Number Publication Date
UA112990C2 true UA112990C2 (uk) 2016-11-25

Family

ID=44675697

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201400940A UA112990C2 (uk) 2011-08-03 2012-02-08 Композиція, яка містить saccharomyces boulardii і супероксиддисмутазу, для боротьби з ожирінням

Country Status (25)

Country Link
US (1) US9555082B2 (uk)
EP (1) EP2739295B1 (uk)
JP (1) JP6126595B2 (uk)
KR (1) KR101954674B1 (uk)
CN (1) CN103764156A (uk)
AU (1) AU2012292029B2 (uk)
BR (1) BR112014001336A2 (uk)
CA (1) CA2843794C (uk)
CY (1) CY1117187T1 (uk)
DK (1) DK2739295T3 (uk)
ES (1) ES2562647T3 (uk)
GE (1) GEP20166436B (uk)
HR (1) HRP20160293T1 (uk)
HU (1) HUE027121T2 (uk)
IL (1) IL230723B (uk)
IT (1) ITMI20111488A1 (uk)
MX (1) MX349242B (uk)
PL (1) PL2739295T3 (uk)
RS (1) RS54594B1 (uk)
RU (1) RU2600843C2 (uk)
SI (1) SI2739295T1 (uk)
SM (1) SMT201600086B (uk)
UA (1) UA112990C2 (uk)
WO (1) WO2013017650A2 (uk)
ZA (1) ZA201400758B (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
KR101893735B1 (ko) * 2018-05-04 2018-08-31 주식회사이-글벳 열 안정성이 강화된 효모를 이용한 정장효능이 있는 산제 동물용 의약품 조성물 및 그 제조 방법
WO2024002150A1 (en) * 2022-06-29 2024-01-04 Microbiota I - Center (Magic) Limited Methods and compositions for treating obesity using microorganisms

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN101172118A (zh) 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
KR20080094459A (ko) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 항산화 활성을 갖는 화장료 조성물
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
CN101130068B (zh) * 2007-09-04 2010-05-19 陈坤鑫 Sod减肥酒及其生产方法
LT2227539T (lt) * 2007-12-26 2017-11-27 Lesaffre Et Compagnie Žmonių ir (arba) gyvūnų mitybai skirta kompozicija, jos panaudojimas ir mielės
BRPI0907875A2 (pt) * 2008-02-14 2015-07-21 Barley & Oats Co Ltd Produto fermentado produzido por adição de microorganismo comestível e método para produzir produto fermentado
US20110091553A1 (en) * 2008-06-02 2011-04-21 Kaneka Corporation Method for producing microcapsules using solid fat
JP2010100530A (ja) * 2008-10-21 2010-05-06 Ikeda Shokken Kk 抗肥満剤
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
DK3181134T3 (da) 2009-06-19 2020-01-20 Dupont Nutrition Biosci Aps Bifidobakterier til behandling af diabetes og relaterede tilstande
JP2011004640A (ja) * 2009-06-24 2011-01-13 Kaneka Corp 魚介エキスの精製方法
US20120121562A1 (en) * 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'

Also Published As

Publication number Publication date
HUE027121T2 (en) 2016-08-29
RS54594B1 (en) 2016-08-31
KR20140051279A (ko) 2014-04-30
PL2739295T3 (pl) 2016-06-30
HRP20160293T1 (hr) 2016-04-22
BR112014001336A2 (pt) 2017-07-04
CA2843794C (en) 2021-11-09
ZA201400758B (en) 2015-10-28
CY1117187T1 (el) 2017-04-05
DK2739295T3 (en) 2016-03-14
US9555082B2 (en) 2017-01-31
WO2013017650A2 (en) 2013-02-07
ITMI20111488A1 (it) 2013-02-04
SI2739295T1 (sl) 2016-04-29
JP2014521343A (ja) 2014-08-28
CA2843794A1 (en) 2013-02-07
US20140205581A1 (en) 2014-07-24
EP2739295B1 (en) 2015-12-30
SMT201600086B (it) 2016-04-29
KR101954674B1 (ko) 2019-03-06
GEP20166436B (en) 2016-02-25
WO2013017650A3 (en) 2013-04-04
AU2012292029B2 (en) 2017-03-09
AU2012292029A1 (en) 2014-02-20
MX349242B (es) 2017-07-18
RU2600843C2 (ru) 2016-10-27
RU2014103483A (ru) 2015-08-10
NZ620579A (en) 2015-11-27
CN103764156A (zh) 2014-04-30
IL230723B (en) 2018-01-31
ES2562647T3 (es) 2016-03-07
MX2014001327A (es) 2014-02-27
IL230723A0 (en) 2014-03-31
EP2739295A2 (en) 2014-06-11
JP6126595B2 (ja) 2017-05-10

Similar Documents

Publication Publication Date Title
TWD160278S (zh) 行動電話
TWD150044S (zh) 行動電話保護套
TWD158841S (zh) 可攜式電腦之罩蓋
TWD164765S (zh) 筆記型電腦外殼之部分
EP2576580A4 (en) REDUCTION OF LACTATE LEVEL AND INCREASE IN POLYPEPTIDE PRODUCTION BY NEGATIVE REGULATION OF LACTATE DEHYDROGENASE AND PYRUVATE DEHYDROGENASE KINASE EXPRESSION
TWD168545S (zh) 錶圈
TWD163747S (zh) 顯示螢幕的圖像
GB201304865D0 (en) Multiply add functional unit capable of executing scale, round, get-mant, reduce, range and class instructions
GB201217266D0 (en) Performing aggressive code optimization with an ability to rollback changes made by the aggressive optimizations
ECSP12012105A (es) Antídotos de Anticoagulantes
GB201101387D0 (en) A pellet
GT201200293A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
TWD158887S (zh) 粉餅盒
TWD163746S (zh) 顯示螢幕的圖像
TWD163159S (zh) 筆記型電腦外殼之部分
UA112990C2 (uk) Композиція, яка містить saccharomyces boulardii і супероксиддисмутазу, для боротьби з ожирінням
IN2014CH02384A (uk)
TWD163737S (zh) 顯示螢幕之圖像
TWD154764S (zh) 凳椅
BR112018072150A2 (pt) equilíbrio de redox em levedura
MX2015002908A (es) Polipeptido con actividad reforzada de beta-glucosidasa a baja temperatura.
TWD157099S (zh) 測重儀用應變片
RU2009133512A (ru) Способ реанимации при отравлении зоотоксинами
TWD157394S (zh) 行動電話保護殼
石田紀子 Development of the theory of transportability and its application to risk assessment of metabolic syndrome